Physician profile
Laneshia N Patrick
NPI 1942690847
$562.52
in general payments reported to CMS, 2019-2025
9 companies · $24.23 in 2025
The $24.23 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.25 · 2022: $223 · 2023: $222 · 2024: $66.89 · 2025: $24.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $154.61 | 2021-2024 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $123.01 | 2021-2023 | Ztlido |
| Boston Scientific Corporation | $102.50 | 2022 | |
| Protega Pharmaceutials INC | $54.61 | 2023 | Roxybond |
| Valinor Pharma, LLC | $37.78 | 2023-2024 | Movantik |
| Azurity Pharmaceuticals, INC. | $31.31 | 2024 | Horizant |
| Abbott Laboratories | $24.23 | 2025 | Eterna |
| Lundbeck LLC | $22.82 | 2022 | |
| Biodelivery Sciences International, INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laneshia Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.